Search company, investor...

Founded Year


About Akesis

Akesis is a company focused on innovating radiation medicine within the healthcare sector. It offers advanced radiotherapy treatment systems that combine gamma-beam therapy with rotational technology to optimize treatment planning and delivery, as well as incorporating real-time imaging for precision. The company's products are designed to provide simple, safe, and reliable treatment delivery technologies to the healthcare industry. It was founded in 2018 and is based in Concord, California.

Headquarters Location

5129 Commercial Circle

Concord, California, 94520,

United States




Latest Akesis News

Gamma Knife Market Size, & Trends Analysis Report 2023-2030 Featuring Key Players - Elekta, Huiheng Medical, MASEP Medical Science Technology Development, Akesis, & Varian Medical Systems

Oct 5, 2023

The global gamma knife market size is expected to reach USD 626.4 million by 2030, according to this report. It is expected to grow at a CAGR of 5.0% from 2023 to 2030 The increasing prevalence of cancer, brain tumors, and other neurological diseases, rising adoption of these instruments in surgery centers, growing preference for Minimally Invasive Surgeries (MIS), and technological advancements in the device are among few factors expected to drive the market. Gamma knife therapy is used for the treatment of various brain and neurological disorders such as brain tumors, brain metastases, epilepsy, and arteriovenous malformations. Demand for these instruments in surgery centers is growing due to their various advantages such as safety, micro-precision, lack of postsurgical complications, and lack of incisions. Technological advancements have improved precision in surgery. For instance, the up-gradation of Leksell Gamma Knife models U, B, C/4C, and Perfexion to Icon provided micro-precision in surgery and boosted the adoption of this device in surgery centers. According to reports published by Elekta AB, approximately 70,000 patients undergo gamma knife surgery each year. This number is expected to increase over the forecast period owing to the rising prevalence of target diseases and increasing preference for MIS. In addition, the growing demand for MIS over open surgeries is one of the key factors responsible for increasing the adoption of this therapy. Gamma knife treatment procedure results in fewer traumas and faster recovery as compared to open surgeries. It helps reduce hospital stays, thus ensuring economic viability and reduction in medical expenses. Lack of incisions and post-surgical complications are key factors responsible for boosting the demand for minimally invasive surgeries. Key Attributes:

Akesis Frequently Asked Questions (FAQ)

  • When was Akesis founded?

    Akesis was founded in 2018.

  • Where is Akesis's headquarters?

    Akesis's headquarters is located at 5129 Commercial Circle, Concord.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.